Evidence map›Paper›PMID 30696802›Full record

ArticleAging2019

Jiafa He, Li Deng, Heping Liu, Taiying Chen, Shengying Chen, Shangzhou Xia, Yubin Liu

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Aging, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. The role of PI3K/Akt signaling pathway in chronic kidney disease.International urology and nephrology · 2024
    Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Jiafa HeDepartment of Hepatobiliary Surgery, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzho, Guangdong 510080, China.
Li DengGuangzhou Beogene Biotech CO., Ltd., Guangzho, Guangdong 510000, China.
Heping LiuGuangzhou Yiyang Bio-technology Co., Ltd, Guangzho, Guangdong 510000, China.
Taiying ChenGuangzhou Beogene Biotech CO., Ltd., Guangzho, Guangdong 510000, China.
Shengying ChenDepartment of Hepatobiliary Surgery, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzho, Guangdong 510080, China.
Shangzhou XiaGuangzhou Yiyang Bio-technology Co., Ltd, Guangzho, Guangdong 510000, China.
Yubin LiuDepartment of Hepatobiliary Surgery, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzho, Guangdong 510080, China.
Guangdong Academy of Medical Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to investigate

Indexed as

AutophagyBeclin-1Carcinoma, HepatocellularCells, CulturedGene Expression Regulation, NeoplasticHumansLiver NeoplasmsPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktProto-Oncogene Proteins c-bcl-2RNA, MessengerSignal TransductionBCL2-like 10 proteinBeclin-1BECN1 protein, humanPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktProto-Oncogene Proteins c-bcl-2RNA, MessengerautophagyBCL2L10BECN1 (Beclin 1)hepatocellular carcinomaPI3KC3

Identifiers

PMID30696802
PMCPMC6366968
OpenAlexW2913484716

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.